Multiple Sclerosis (MS) affects more than 2.3 million people worldwide; March is Multiple Sclerosis Education Awareness Month®, supported by the Multiple Sclerosis Foundation, with the theme, “MS Counts”. The purpose is to help raise awareness of multiple sclerosis throughout your community and help improve the lives today for people with MS and their families. So here is some patient specific information to bring you up to date.
Multiple Sclerosis is an auto immune disorder in which the immune system attacks these myelin sheaths leading to demyelination and scarring of axons, affecting the transmission of signals. Due to the diverse involvement of axons in many functions this damage can be associated with many co-morbid conditions. In fact, 70% of UK MS patients present an EDSS score of higher than 4.0, and over half of these patients are categorised as severe.
MS is a progressive disease and is categorised into 4 sub-types; relapsing-remitting, primary-progressive, secondary-progressive and progressive-relapsing. It affects both men and women globally and, despite typically presenting in a patient’s 30s, onset can appear at any age. This inclusivity combined with its progressive nature produces great variations from one patient to another. Our database explores these variations and is divided into over 80 sub-populations calculated for 8 countries, spanning 4 continents.
Did you know...Only 46% of German patients present with relapsing-remitting MS, a sub-type that accounts for three quarters of Brazilian patients?